An adequacy decision on the UK data protection regime

To remain competitive, Europe needs longer-term investment, incentives and global regulatory harmonisation

Platform trials would prove especially helpful in rare disease research. Since these illnesses affect small to very...

Intellectual property is a key ingredient in COVID-19 vaccine development

Let’s take a look at the overall picture of bringing new cancer treatments to European patients across all three access...